D.E. Shaw & Co’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

D.E. Shaw & Co’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-7,700	Closed	-$213K	–	4820
2014 Q1	$213K	Buy	+7,700	New	+$201K	﹤0.01%	4057

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

D.E. Shaw & Co's BRLI Position: Q3 2015 in Review

D.E. Shaw & Co sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 273,638 shares — an estimated $11.3M sold.

D.E. Shaw & Co first reported a position in BRLI in Q4 2013 and held it in 7 quarters. The position peaked at $11.3M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

D.E. Shaw & Co reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
D.E. Shaw & Co sold 273,638 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $11.3M.
D.E. Shaw & Co first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 7 quarters.
D.E. Shaw & Co's BIO-REFERENCE LABS INC-NEW- position peaked at $11.3M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on D.E. Shaw & Co's 13F filing for Q3 2015, filed 16 Nov 2015.